394 related articles for article (PubMed ID: 37275361)
1. Barriers to overcoming immunotherapy resistance in glioblastoma.
Gillette JS; Wang EJ; Dowd RS; Toms SA
Front Med (Lausanne); 2023; 10():1175507. PubMed ID: 37275361
[TBL] [Abstract][Full Text] [Related]
2. Advances in immunotherapy for glioblastoma multiforme.
Mahmoud AB; Ajina R; Aref S; Darwish M; Alsayb M; Taher M; AlSharif SA; Hashem AM; Alkayyal AA
Front Immunol; 2022; 13():944452. PubMed ID: 36311781
[TBL] [Abstract][Full Text] [Related]
3. Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds.
Asija S; Chatterjee A; Yadav S; Chekuri G; Karulkar A; Jaiswal AK; Goda JS; Purwar R
Int Rev Immunol; 2022; 41(6):582-605. PubMed ID: 35938932
[TBL] [Abstract][Full Text] [Related]
4. Current Immunotherapies for Glioblastoma Multiforme.
Huang B; Li X; Li Y; Zhang J; Zong Z; Zhang H
Front Immunol; 2020; 11():603911. PubMed ID: 33767690
[TBL] [Abstract][Full Text] [Related]
5. Emerging therapies for glioblastoma: current state and future directions.
Rong L; Li N; Zhang Z
J Exp Clin Cancer Res; 2022 Apr; 41(1):142. PubMed ID: 35428347
[TBL] [Abstract][Full Text] [Related]
6. Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme.
Marei HE; Althani A; Afifi N; Hasan A; Caceci T; Pozzoli G; Cenciarelli C
Cancer Med; 2021 Aug; 10(15):5019-5030. PubMed ID: 34145792
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy Resistance in Glioblastoma.
Wang EJ; Chen JS; Jain S; Morshed RA; Haddad AF; Gill S; Beniwal AS; Aghi MK
Front Genet; 2021; 12():750675. PubMed ID: 34976006
[TBL] [Abstract][Full Text] [Related]
8. Immune Checkpoint Inhibitors and Glioblastoma: A Review on Current State and Future Directions.
Ser MH; Webb MJ; Sener U; Campian JL
J Immunother Precis Oncol; 2024 May; 7(2):97-110. PubMed ID: 38721406
[TBL] [Abstract][Full Text] [Related]
9. Emerging immunotherapies for glioblastoma.
Desai R; Suryadevara CM; Batich KA; Farber SH; Sanchez-Perez L; Sampson JH
Expert Opin Emerg Drugs; 2016 Jun; 21(2):133-45. PubMed ID: 27223671
[TBL] [Abstract][Full Text] [Related]
10. CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma.
Maggs L; Cattaneo G; Dal AE; Moghaddam AS; Ferrone S
Front Neurosci; 2021; 15():662064. PubMed ID: 34113233
[TBL] [Abstract][Full Text] [Related]
11. Current Advances in Immunotherapy for Glioblastoma Multiforme and Future Prospects.
Chowdhury S; Bappy MH; Clocchiatti-Tuozzo S; Cheeti S; Chowdhury S; Patel V
Cureus; 2021 Dec; 13(12):e20604. PubMed ID: 35103180
[TBL] [Abstract][Full Text] [Related]
12. Navigating the Immune Challenge in Glioblastoma: Exploring Immunotherapeutic Avenues for Overcoming Immune Suppression.
Jain P; Vashist S; Panjiyar BK
Cureus; 2023 Sep; 15(9):e46089. PubMed ID: 37900496
[TBL] [Abstract][Full Text] [Related]
13. Neoantigen discovery and applications in glioblastoma: An immunotherapy perspective.
Wang C; Yu M; Zhang W
Cancer Lett; 2022 Dec; 550():215945. PubMed ID: 36216148
[TBL] [Abstract][Full Text] [Related]
14. Insight into the Progress in CAR-T Cell Therapy and Combination with Other Therapies for Glioblastoma.
Liang T; Song Y; Gu L; Wang Y; Ma W
Int J Gen Med; 2023; 16():4121-4141. PubMed ID: 37720174
[TBL] [Abstract][Full Text] [Related]
15. Prospective approaches to enhancing CAR T cell therapy for glioblastoma.
Choi SI; Yin J
Front Immunol; 2022; 13():1008751. PubMed ID: 36275671
[TBL] [Abstract][Full Text] [Related]
16. An Update on the Role of Immunotherapy and Vaccine Strategies for Primary Brain Tumors.
Neagu MR; Reardon DA
Curr Treat Options Oncol; 2015 Nov; 16(11):54. PubMed ID: 26454859
[TBL] [Abstract][Full Text] [Related]
17. CAR T Cell Therapy in Glioblastoma: Overcoming Challenges Related to Antigen Expression.
Luksik AS; Yazigi E; Shah P; Jackson CM
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900205
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic strategies of recurrent glioblastoma and its molecular pathways 'Lock up the beast'.
El-Khayat SM; Arafat WO
Ecancermedicalscience; 2021; 15():1176. PubMed ID: 33680090
[TBL] [Abstract][Full Text] [Related]
19. Advances in Glioblastoma Therapy: An Update on Current Approaches.
Angom RS; Nakka NMR; Bhattacharya S
Brain Sci; 2023 Oct; 13(11):. PubMed ID: 38002496
[TBL] [Abstract][Full Text] [Related]
20. Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence.
Kreatsoulas D; Bolyard C; Wu BX; Cam H; Giglio P; Li Z
J Hematol Oncol; 2022 Jun; 15(1):80. PubMed ID: 35690784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
